Skip to main content
OpenTrials
Completed

NCT Number: NCT07150065

Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever

Sample size of 360 children with typhoid fever were enrolled and randomly divided in two groups. All the children were enrolled in the trial from Pediatrics emergency. Informed consent was obtained from parents. Demographics (name, age of child, sex of the child, duration of fever, weight, season, socioeconomic status and residence) were noted. Then children were admitted and randomly divided in two groups by using lottery method. In group A, children were given oral 200 mg levofloxacin tablet. In group B, children were given oral 900-1,000 mg ciprofloxacin tablet. All children were followed-up pediatric wards for 7 days. If fever was resolved within 5 days (body temperature falls <99oF and remain stable for at least 5 days), then efficacy was labeled. Total time required to resolve fever i.e. body temperature <99oF in all children was also noted. All this information was recorded

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Avicenna Hospital Lahore

Lahore, Punjab Province, 54000, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children of age 1-12 years
  • Typhoid fever
  • Confirmed on blood culture

Exclusion criteria

  • Recurrent typhoid within 3 months
  • Intestinal perforation
  • Evidence of progressive or complicated disease
  • Inability to swallow oral medication
  • Hypersensitivity to trial drugs
  • Already taken fluoroquinolone, third generation cephalosporin or macrolide in last week

Treatment and study plan

Levofloxacin

Drug

Oral 200 mg levofloxacin tablet

Ciprofloxacin

Drug

Oral 900-1,000 mg ciprofloxacin tablet

Primary outcomes

  1. Total time required to resolve fever

    Time frame: 5 days

    Clinical efficacy involved resolution of fever within 5 days (body temperature falls <99oF and remain stable for at least 5 days). Total time required to resolve fever i.e. body temperature <99oF in all children was also noted.

Sponsors and collaborators

Lead sponsor

Avicenna Medical College Lahore

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 2, 2025
Registry last updated
Sep 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.